ASTRAZENECA's OMEPRAZOLE FORMULATION PATENTS AstraZeneca today announced that the Tel Aviv District Court has upheld the formulation patents for omeprazole. This follows an appeal by AstraZeneca and the Israeli company Unipharm. The District Court found that the inventions subject to the patents constituted a significant advance over prior art and that they were not obvious. Omeprazole is the substance used in Losec®.
This website is intended for people seeking information on AstraZeneca's International business. We also have national business sites; links to these are under 'Other AZ websites' at the top of the page.